Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |